Yooyoung Pharmaceutical
CompanySouth Korea
Yooyoung Pharmaceutical develops one asset, approved (celecoxib in acute pain). Mostly small molecule acting on inflammation, PTGS2 and OPRM1; based in South Korea.
- 1
- Asset
- Furthest
- Approved
- 4
- Trials
- 0
- Signals
Pipeline
1Selective cyclooxygenase-2 inhibitor reducing prostaglandin synthesis to relieve pain and inflammation
Approved, Small molecule, Inflammation, PTGS2, acute pain, adenomatous polyposis coli
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms4
- Trials4
- Similar companies6
Updated 7 Oct 2026 · 59 sources